Is Artificial Intelligence reimbursable? How the value of a new technology is determined and claims assessed
Read more in our latest opinion piece by Director of Market Access Carrie Hart.
optellum.com/2023/12/is-art…
We are a lung health company, providing artificial intelligence software for clinicians to make the best decisions for early diagnosis and optimal treatment.
- Lung Cancer Awareness Month is a poignant reminder of the urgent need to spotlight one of the most prevalent and deadliest forms of cancer worldwide. Find out more about our innovative solution here optellum.com/2023/11/lung-c…
- Lung cancer is the #1 cancer killer. This #worldlungcancerday we're launching our new video showing how Optellum can help clinicians with the only AI-based lung cancer clinical solution for early diagnosis. youtu.be/Bxuzs44C68s?si…
- Optellum's vision is to redefine early intervention of lung cancer, enabling every clinician, in every hospital, to make the right decisions and give patients the best chance to fight back. #WorldLungCancerDay
- It's time to get serious about incidental lung cancer detection. Optellum's Ryan Hennen speaks to @healthitanswers about challenges in care pathways from broken workflows to low ROI and how the cost-benefit equation is changing. healthitanswers.net/its-time-to-ge… #lungcancer #aiinmedicine

